141 related articles for article (PubMed ID: 6178872)
1. Mechanisms of proteinuria in diabetic nephropathy: a study of glomerular barrier function.
Myers BD; Winetz JA; Chui F; Michaels AS
Kidney Int; 1982 Apr; 21(4):633-41. PubMed ID: 6178872
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of proteinuria in diabetic nephropathy. II. A study of the size-selective glomerular filtration barrier.
Friedman S; Jones HW; Golbetz HV; Lee JA; Little HL; Myers BD
Diabetes; 1983 May; 32 Suppl 2():40-6. PubMed ID: 6086024
[TBL] [Abstract][Full Text] [Related]
3. Proteinuria and functional characteristics of the glomerular barrier in diabetic nephropathy.
Carrie BJ; Myers BD
Kidney Int; 1980 May; 17(5):669-76. PubMed ID: 6157049
[TBL] [Abstract][Full Text] [Related]
4. Functional nature of glomerular injury in progressive diabetic glomerulopathy.
Tomlanovich S; Deen WM; Jones HW; Schwartz HC; Myers BD
Diabetes; 1987 May; 36(5):556-65. PubMed ID: 2436961
[TBL] [Abstract][Full Text] [Related]
5. Glomerular permselectivity in early stages of overt diabetic nephropathy.
Andersen S; Blouch K; Bialek J; Deckert M; Parving HH; Myers BD
Kidney Int; 2000 Nov; 58(5):2129-37. PubMed ID: 11044234
[TBL] [Abstract][Full Text] [Related]
6. Glomerular function in advanced human diabetic nephropathy.
Winetz JA; Golbetz HV; Spencer RJ; Lee JA; Myers BD
Kidney Int; 1982 May; 21(5):750-6. PubMed ID: 6180214
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of proteinuria in human glomerulonephritis.
Myers BD; Okarma TB; Friedman S; Bridges C; Ross J; Asseff S; Deen WM
J Clin Invest; 1982 Oct; 70(4):732-46. PubMed ID: 6181095
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of proteinuria in diabetic glomerular disease.
Myers BD
J Hypertens Suppl; 1990 Mar; 8(1):S41-6. PubMed ID: 2332816
[TBL] [Abstract][Full Text] [Related]
9. Effects of exercise on glomerular passage of macromolecules in patients with diabetic nephropathy and in healthy subjects.
Ala-Houhala I
Scand J Clin Lab Invest; 1990 Feb; 50(1):27-33. PubMed ID: 1690442
[TBL] [Abstract][Full Text] [Related]
10. Fractional dextran and protein clearances in glomerulonephritis and in diabetic nephropathy.
Ala-Houhala I; Pasternack A
Clin Sci (Lond); 1987 Mar; 72(3):289-96. PubMed ID: 2434282
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of proteinuria in immune glomerular injury.
Myers BD
Am J Nephrol; 1990; 10 Suppl 1():19-23. PubMed ID: 1701613
[TBL] [Abstract][Full Text] [Related]
12. Glomerular selective permeability to macromolecular neutral dextrans in experimental diabetes.
Pennell JP; Yanagawa N; Hwang KH; Millard MM; Bourgoignie JJ
Diabetologia; 1981 Mar; 20(3):223-7. PubMed ID: 6164592
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of the puromycin-induced defects in the transglomerular passage of water and macromolecules.
Bohrer MP; Baylis C; Robertson CR; Brenner BM; Troy JL; Willis WT
J Clin Invest; 1977 Jul; 60(1):152-61. PubMed ID: 874080
[TBL] [Abstract][Full Text] [Related]
14. Minimal change nephropathy: an electrochemical disorder of the glomerular membrane.
Carrie BJ; Salyer WR; Myers BD
Am J Med; 1981 Feb; 70(2):262-8. PubMed ID: 6162382
[TBL] [Abstract][Full Text] [Related]
15. Charge selectivity of proteinuria in diabetic glomerulopathy.
Nakamura Y; Myers BD
Diabetes; 1988 Sep; 37(9):1202-11. PubMed ID: 3410164
[TBL] [Abstract][Full Text] [Related]
16. Glomerular size-selectivity and microalbuminuria in early diabetic glomerular disease.
Scandling JD; Myers BD
Kidney Int; 1992 Apr; 41(4):840-6. PubMed ID: 1381005
[TBL] [Abstract][Full Text] [Related]
17. Molecular configuration and glomerular size selectivity in healthy and nephrotic humans.
Blouch K; Deen WM; Fauvel JP; Bialek J; Derby G; Myers BD
Am J Physiol; 1997 Sep; 273(3 Pt 2):F430-7. PubMed ID: 9321916
[TBL] [Abstract][Full Text] [Related]
18. Nature of the glomerular capillary injury in human membranous glomerulopathy.
Shemesh O; Ross JC; Deen WM; Grant GW; Myers BD
J Clin Invest; 1986 Mar; 77(3):868-77. PubMed ID: 2419362
[TBL] [Abstract][Full Text] [Related]
19. Glomerular dysfunction in nephrotic humans with minimal changes or focal glomerulosclerosis.
Guasch A; Hashimoto H; Sibley RK; Deen WM; Myers BD
Am J Physiol; 1991 May; 260(5 Pt 2):F728-37. PubMed ID: 1709791
[TBL] [Abstract][Full Text] [Related]
20. Heteroporous model of glomerular size selectivity: application to normal and nephrotic humans.
Deen WM; Bridges CR; Brenner BM; Myers BD
Am J Physiol; 1985 Sep; 249(3 Pt 2):F374-89. PubMed ID: 4037090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
